- Home
- XLO vs MODV Comparison
XLO vs MODV Comparison
Compare XLO & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XLO
- MODV
- Stock Information
- Founded
- XLO 2016
- MODV 1996
- Country
- XLO United States
- MODV United States
- Employees
- XLO N/A
- MODV N/A
- Industry
- XLO Biotechnology: Pharmaceutical Preparations
- MODV Transportation Services
- Sector
- XLO Health Care
- MODV Consumer Discretionary
- Exchange
- XLO Nasdaq
- MODV Nasdaq
- Market Cap
- XLO 42.2M
- MODV 48.9M
- IPO Year
- XLO 2021
- MODV N/A
- Fundamental
- Price
- XLO $0.71
- MODV $3.33
- Analyst Decision
- XLO Buy
- MODV Buy
- Analyst Count
- XLO 1
- MODV 4
- Target Price
- XLO $4.00
- MODV $9.17
- AVG Volume (30 Days)
- XLO 389.5K
- MODV 940.8K
- Earning Date
- XLO 08-07-2025
- MODV 08-06-2025
- Dividend Yield
- XLO N/A
- MODV N/A
- EPS Growth
- XLO N/A
- MODV N/A
- EPS
- XLO N/A
- MODV N/A
- Revenue
- XLO $9,274,000.00
- MODV $2,753,789,000.00
- Revenue This Year
- XLO $300.08
- MODV N/A
- Revenue Next Year
- XLO $1.87
- MODV $4.90
- P/E Ratio
- XLO N/A
- MODV N/A
- Revenue Growth
- XLO N/A
- MODV N/A
- 52 Week Low
- XLO $0.62
- MODV $0.87
- 52 Week High
- XLO $1.70
- MODV $32.82
- Technical
- Relative Strength Index (RSI)
- XLO 48.89
- MODV 52.35
- Support Level
- XLO $0.67
- MODV $3.01
- Resistance Level
- XLO $0.75
- MODV $4.20
- Average True Range (ATR)
- XLO 0.03
- MODV 0.41
- MACD
- XLO 0.01
- MODV -0.08
- Stochastic Oscillator
- XLO 64.56
- MODV 23.53
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.